Thomas Galloway, MD

Thomas Galloway, MD
(4.9/5.0)
101 Patient Satisfaction Ratings
Request an Appointment

Clinical Locations

Associate Professor, Department of Radiation Oncology

Chief, Division of Head and Neck Radiation Oncology

Medical Director, Clinical Research

 

Treatment Focus

  • Intensity modulated radiation therapy
  • Stereotactic body radiation therapy
  • Modulated electron beam therapy
  • Interstitial brachytherapy
  • Rotational arc therapy

Research Program

Key Awards

  • ARRO Educator of the year, Fox Chase Cancer Center 2013
  • Practical Radiation Oncology, Certificate in Excellence of Reviewing, 2013

    Treatment Philosophy

    I joined Fox Chase after completing my residency at the University of Florida in 2010. I specialize in treating cancers of the head and neck and skin cancer.

    Cancer is a complicated, confusing diagnosis. Cancers of the head and neck are particularly challenging because they occur in areas that can affect our ability to perform some of our most basic functions: breathing, speaking, and eating.

    I came to Fox Chase because I believe that the best way to cure these difficult cancers while maintaining quality of life is through a multi-disciplinary approach. Some cancers are cured with radiation alone, some need the assistance of both surgery and chemotherapy, and some are cured without radiation. The team approach at Fox Chase ensures that many different disciplines are working together to decide the best treatment for your unique case with one unifying goal: curing your cancer while avoiding unnecessary toxicity

    Educational Background

    • MD, University of Florida, Gainesville, FL, 2005
    • BS, Chemistry, University of Florida, Gainesville, FL, 2001

    Certifications

    • American Board of Radiology
    • Radiation Oncology

    Memberships

    • American Society of Therapeutic Radiology (ASTRO)
    • Radiation Therapy Oncology Group (RTOG)
    • Institutional Principal Investigator for Fox Chase Cancer Center (Institution 2212) July 2013 - Present
    • American Radium Society (ARS)
    • Radiological Society of North America (RSNA)
    • American College of Radiology (ACR)
    • Eastern Cooperative Oncology Group (ECOG)

      Honors & Awards

      • ARRO Educator of the year, Fox Chase Cancer Center 2013
      • Practical Radiation Oncology, Certificate in Excellence of Reviewing, 2013

      Jack Gullo

      • Head & Neck Cancer

      A few days before leaving on my vacation in August, 2017, I noticed a loose tooth. My biggest worry was that maybe I had an abscess and it would ruin my trip.

      When I got home, my dentist said I should have it pulled, so I went to an oral surgeon. The oral surgeon said, “I see something, so I’m going to do a biopsy.” I kind of knew right then that I had cancer.

      VIEW PATIENT STORY

      Linda Rathbun

      • Head & Neck Cancer

      I tell people if you are going on this journey, you should not compare yourself to anyone else. Every cancer is different, and every person’s situation is different.

      VIEW PATIENT STORY

      Tierra Ryan

      • Lymphoma

      At 31, Tierra Ryan was a young professional woman, working as a pharmacist and a medical writer for a large pharmaceutical company, when she was shocked to learn she was diagnosed with Hodgkin's lymphoma. Fox Chase Cancer Center was one of two hospitals her doctor recommended. Tierra underwent chemotherapy and radiation therapy at Fox Chase, and in November 2014 was placed on surveillance because her cancer was in remission. Today, she still works in the pharmaceutical industry, but as a medical science liaison focusing on oncology. "I’m truly thankful to the doctors and staff at Fox Chase because they saved my life," Tierra said. "Because of them, I have a long life ahead of me."

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

       

      VIEW PATIENT STORY

      Stephen Meier

      • Head & Neck Cancer

      "I’m the kind of person who isn’t prone to panic. Panic just causes confusion. So, when what began as soreness on the right side of my throat turned out to be cancer, I remained calm and figured somebody can fix it."

      VIEW PATIENT STORY

      Research Interests

      • Head and neck cancer
      • Head and neck cancer survivorship
      • Skin Cancer (both melanoma and non-melanoma)
      • Merkel Cell Carcinoma Radiation target delineation
      • Pre-treatment imaging evaluation beyond the diagnosis
      • Impact of time to treatment in the curative management of head and neck cancer

      Selected Publications

      Ebersole B., McCarroll L., Ridge J.A., Liu J.C., Bauman J., Donnelly S., Galloway T.J., Identification and management of late dysfunction in survivors of head and neck cancer: Implementation and outcomes of an interdisciplinary quality of life (iqol) clinic. Head Neck. 43(7): 2124-2135, 2021. https://www.ncbi.nlm.nih.gov/pubmed/33749012.

      Lee C.T., Galloway T.J., Pathogenesis and amelioration of radiation-induced oral mucositis. Curr Treat Options Oncol. 23(3): 311-324, 2022. PMC8931694. https://www.ncbi.nlm.nih.gov/pubmed/35244887.

      Murphy CT, Galloway TJ, Handorf EA, Wang L, Mehra R, Flieder D, Ridge JA. The Survival Impact of Increasing Time to Treatment Initiation for Patients with Head and Neck Cancer in the United States. Accepted for publication in Journal of Clinical Oncology PubMed

      Murphy CT, Devarajan K, Wang LS, Mehra R, Ridge JA, Fundakowski C, Galloway TJ. Pre-Treatment Tumor-Specific Growth Rate as a Temporal Biomarker that Predicts Treatment Failure and Improves Risk Stratification for Oropharyngeal Cancer. Accepted for publication in Oral Oncology PubMed

      Lango MN, Galloway TJ, Mehra R, Ebersole B, Liu JC, Burtness B, Moran K, Ridge JA.  Impact of baseline dysphagia on acute feeding tube placement in head and neck cancer patients undergoing definitive radiation.  Epub ahead of print in Head and Neck PubMed

      Galloway TJ, Ridge JA.  Management of squamous cancer metastatic to cervical nodes with unknown primary.  Epub ahead of print in Journal of Clinical Oncology PubMed

      Galloway TJ, Wirth L, Colevas D, Gilbert J, Bauman J, Saba N, Raben D, Mehra R, Burtness B, Jimeno A. A Phase 1 Study of CUDC-101, a multitarget inhibitor of HDACs, EGFR and HER2, in combination with chemoradiation in patients with head and neck squamous cell carcinoma (Clinical Cancer Research 2015; 21(7) 1566-1573). PubMed

      Murphy CT, Galloway TJ, Handorf EA, Wang L, Mehra R, Flieder D, Ridge JA. Increasing time to treatment initiation for squamous cell carcinoma of the head and neck: An analysis of the National Cancer Database. (Cancer 2015; 121(8) 1204-1213). PubMed

      Nguyen-Tan PF, Zhang QE, Ang KK, Wheeler RH, Weber RS, Rosenthal DI, Bahary JP, Kim H, Silverman C, Raben A, Galloway T, Vigneault E, Gore E, Westra WH, Chung CH, Jordan RC, Gillison ML, List M, Le QT. A Randomized Phase III Trial to Test Accelerated versus Standard Fractionation in Combination with Concurrent Cisplatin for Head and Neck Carcinomas (RTOG 0129): Long Term Report of Efficacy and Toxicity. (Journal of Clinical Oncology 2014; 32(34) 3858-3867 

      Lango MN, Egleston B, Fang CY, Burtness B, Galloway T, Liu JC, Mehra R, Ebersole B, Moran KM, Ridge JA. Baseline Health Perceptions, weight-loss and survival in head and neck cancer. (Cancer 2014; 120(6):840-7... Expand

      Additional Publications

      101 patient satisfaction reviews

      Our Patient Satisfaction Rating is an average of all responses to care provider related questions from our nationally-recognized Press Ganey Patient Satisfaction Survey. Learn more.

      Overall Rating

      4.9 / 5.0

      Ratings Breakdown

      4.8
      Gives easy to understand instruction
      4.8
      Explains in a way you understand
      4.9
      Listens carefully to you
      4.9
      Shows respect for what you say
      4.8
      Spends enough time with you

      16 patient comments

      • 5.0
        March 28, 2022

        I can not say enough good things about Dr. Galloway and the entire team who have been with me since the beginning of my cancer journey. They saved my life and have always treated me with respect and dignity. The genuine concern for my overall well being has comforted me throughout this journey!!!

      • 5.0
        November 27, 2021

        Great experience Dr Galloway and his staff are the best!

      • 5.0
        September 14, 2021

        Very nice experience great doctor, have been a patient a long time

      • 5.0
        July 30, 2021

        AN EXCELLENT DOCTOR, ALONG WITH [...], ONE OF THE NURSES!

      • 5.0
        July 28, 2021

        Dr. Galloway is a very informative and attentive Doctor. He gives excellent care.

      • 5.0
        July 16, 2021

        Extremely informative, caring and would do whatever it takes to make your visit comfortable.

      • 5.0
        July 2, 2021

        Very good & pleasant visit.

      • 5.0
        May 21, 2021

        Dr. Galloway and his staff were always pleasant and up beat, full of energy.

      • 5.0
        May 21, 2021

        Dr. Galloway and his team are wonderful - caring, pleasant, and thorough.

      • 5.0
        March 30, 2021

        Dr Galloway and his team they are the best, They saved my life. Thank You

      • 5.0
        March 16, 2021

        Dr. Galloway and all of the staff always gave the best care.

      • 5.0
        February 19, 2021

        Servic was good, on tome and understandable

      • 5.0
        January 24, 2021

        very good as always. No complaints.

      • 5.0
        January 17, 2021

        Every appt with Dr. Galloway and staff is welcoming, courteous, informative and thorough. A joy

      • No Star Ratings Available
        January 3, 2021

        good

      • No Star Ratings Available
        December 31, 2020

        very thorough. Answers all questions.